Trandolapril (Actavis Pharma, Inc.)


Welcome to the PulseAid listing for the Trandolapril drug offered from Actavis Pharma, Inc.. This Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Actavis Pharma, Inc.
NON-PROPRIETARY NAME: Trandolapril
SUBSTANCE NAME: TRANDOLAPRIL
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2007-06-12
END MARKETING DATE: 0000-00-00


Trandolapril HUMAN PRESCRIPTION DRUG Details:

Item DescriptionTrandolapril from Actavis Pharma, Inc.
LABELER NAME: Actavis Pharma, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 1(mg/1)
START MARKETING DATE: 2007-06-12
END MARKETING DATE: 0000-00-00
PRODUCT ID: 16252-541_0615163b-2731-4bc6-b98f-c382aefc31be
PRODUCT NDC: 16252-541
APPLICATION NUMBER: ANDA077805

Other TRANDOLAPRIL Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actavis Pharma, Inc.Trandolapril
Aurobindo Pharma LimitedTrandolapril
Carilion Materials ManagementTrandolapril
Citron Pharma LLCTrandolapril
Dispensing Solutions, Inc.Trandolapril
Epic Pharma, LLCTrandolapril
Lupin Pharmaceuticals, Inc.Trandolapril
Physicians Total Care, Inc.Mavik